Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.

Sharika Nuzhat, Rina Das, Subhasish Das, Shoeb Bin Islam, Parag Palit, Md Ahshanul Haque, Subhra Chakraborty, Soroar Hossain Khan, Dilruba Ahmed, Baharul Alam, Tahmeed Ahmed, Mohammod Jobayer Chisti, A S G Faruque
Author Information
  1. Sharika Nuzhat: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh. ORCID
  2. Rina Das: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh. ORCID
  3. Subhasish Das: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh.
  4. Shoeb Bin Islam: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh.
  5. Parag Palit: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh.
  6. Md Ahshanul Haque: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh.
  7. Subhra Chakraborty: Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  8. Soroar Hossain Khan: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh.
  9. Dilruba Ahmed: Laboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh.
  10. Baharul Alam: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh.
  11. Tahmeed Ahmed: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh.
  12. Mohammod Jobayer Chisti: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh. ORCID
  13. A S G Faruque: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka, Bangladesh.

Abstract

Antimicrobial resistance against shigellosis is increasingly alarming. However, evidence-based knowledge gaps regarding the changing trends of shigellosis in Bangladesh exist due to the scarcity of longitudinal data on antimicrobial resistance. Our study evaluated the last 20 years antimicrobial resistance patterns against shigellosis among under-5 children in the urban and rural sites of Bangladesh. Data were extracted from the Diarrheal Disease Surveillance System (DDSS) of Dhaka Hospital (urban site) and Matlab Hospital (rural site) of the International Centre for Diarrheal Disease Research, Bangladesh (icddr,b) between January 2001 and December 2020. We studied culture-confirmed shigellosis cases from urban Dhaka Hospital (n = 883) and rural Matlab Hospital (n = 1263). Since 2001, a declining percentage of shigellosis in children observed in urban and rural sites. Moreover, higher isolation rates of Shigella were found in the rural site [1263/15684 (8.1%)] compared to the urban site [883/26804 (3.3%)] in the last 20 years. In both areas, S. flexneri was the predominant species. The upward trend of S. sonnei in both the study sites was statistically significant after adjusting for age and sex. WHO-recommended 1st line antibiotic ciprofloxacin resistance gradually reached more than 70% in both the urban and rural site by 2020. In multiple logistic regression after adjusting for age and sex, ciprofloxacin, azithromycin, mecillinam, ceftriaxone, and multidrug resistance (resistance to any two of these four drugs) among under-5 children were found to be increasing significantly (p<0.01) in the last 20 years in both sites. The study results underscore the importance of therapeutic interventions for shigellosis by appropriate drugs based on their current antibiogram for under-5 children. These observations may help policymakers in formulating better case management strategies for shigellosis.

References

  1. Diagn Microbiol Infect Dis. 2008 Jul;61(3):321-8 [PMID: 18358664]
  2. J Infect Public Health. 2018 Jul - Aug;11(4):451-454 [PMID: 29066021]
  3. Clin Microbiol Infect. 2007 Dec;13(12):1141-3 [PMID: 17953700]
  4. J Clin Microbiol. 2020 Mar 25;58(4): [PMID: 31969425]
  5. Glob Health Action. 2019 Dec 13;12(sup1):1824383 [PMID: 33040695]
  6. Lancet. 1994 Jun 4;343(8910):1413-5 [PMID: 7910890]
  7. Pathog Glob Health. 2015;109(7):309-18 [PMID: 26343252]
  8. Antimicrob Agents Chemother. 2020 Nov 17;64(12): [PMID: 33020158]
  9. J Antimicrob Chemother. 2003 Feb;51(2):427-9 [PMID: 12562716]
  10. Nat Genet. 2012 Sep;44(9):1056-9 [PMID: 22863732]
  11. Ann Clin Microbiol Antimicrob. 2019 Jul 9;18(1):22 [PMID: 31288806]
  12. Trans R Soc Trop Med Hyg. 2000 May-Jun;94(3):323-6 [PMID: 10975012]
  13. mSphere. 2016 Dec 21;1(6): [PMID: 28028547]
  14. Appl Environ Microbiol. 2001 Jul;67(7):3328-30 [PMID: 11425764]
  15. Epidemiol Infect. 2015 May;143(7):1377-87 [PMID: 25222698]
  16. Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):544-9 [PMID: 2548865]
  17. Paediatr Int Child Health. 2018 Nov;38(sup1):S50-S65 [PMID: 29790845]
  18. Pediatr Infect Dis J. 1989 Oct;8(10):713-9 [PMID: 2682504]
  19. BMC Infect Dis. 2021 Dec 7;21(1):1231 [PMID: 34876041]
  20. Nat Commun. 2018 Apr 13;9(1):1462 [PMID: 29654279]
  21. PLoS Negl Trop Dis. 2021 Sep 2;15(9):e0009721 [PMID: 34473699]
  22. Antimicrob Agents Chemother. 1997 Oct;41(10):2302-4 [PMID: 9333070]
  23. Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):157-70 [PMID: 23990135]
  24. PLoS Med. 2006 Sep;3(9):e353 [PMID: 16968124]
  25. Infect Drug Resist. 2019 Oct 07;12:3137-3167 [PMID: 31632102]
  26. Ther Adv Infect Dis. 2018 Jan;5(1):29-43 [PMID: 29344358]
  27. Antimicrob Agents Chemother. 1995 Apr;39(4):819-23 [PMID: 7785977]
  28. Paediatr Int Child Health. 2013 Feb;33(1):4-17 [PMID: 23485489]
  29. Trop Med Health. 2019 May 02;47:29 [PMID: 31073272]
  30. J Health Popul Nutr. 2007 Jun;25(2):158-67 [PMID: 17985817]
  31. Clin Infect Dis. 2014 May;58(9):e133-6 [PMID: 24457344]
  32. Pediatr Infect Dis J. 2003 Apr;22(4):374-7 [PMID: 12712971]
  33. Epidemiol Infect. 2011 Mar;139(3):446-52 [PMID: 20478088]
  34. Lancet Infect Dis. 2015 Aug;15(8):913-21 [PMID: 25936611]
  35. mBio. 2021 Jan 26;12(1): [PMID: 33500335]
  36. Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):279-286 [PMID: 32888117]
  37. J Infect Chemother. 2020 Sep;26(9):955-958 [PMID: 32446727]
  38. Emerg Infect Dis. 2016 Jun;22(6):1083-5 [PMID: 27191035]
  39. Front Cell Infect Microbiol. 2016 Apr 19;6:45 [PMID: 27148494]
  40. Emerg Infect Dis. 2007 Jan;13(1):18-24 [PMID: 17370511]
  41. Lancet Glob Health. 2018 Dec;6(12):e1319-e1328 [PMID: 30287125]

Grants

  1. R01 AI153399/NIAID NIH HHS

MeSH Term

Child
Humans
Dysentery, Bacillary
Anti-Bacterial Agents
Bangladesh
Drug Resistance, Bacterial
Diarrhea
Hospitals, Rural
Ciprofloxacin

Chemicals

Anti-Bacterial Agents
Ciprofloxacin

Word Cloud

Created with Highcharts 10.0.0resistanceshigellosisurbanruralchildrensiteBangladeshstudy20yearssitesHospitallastamongunder-5AntimicrobialantimicrobialDiarrhealDiseaseDhakaMatlab20012020n=found]SadjustingagesexciprofloxacindrugsincreasinglyalarmingHoweverevidence-basedknowledgegapsregardingchangingtrendsexistduescarcitylongitudinaldataevaluatedpatternsDataextractedSurveillanceSystemDDSSInternationalCentreResearchicddrbJanuaryDecemberstudiedculture-confirmedcases8831263SincedecliningpercentageobservedMoreoverhigherisolationratesShigella[1263/1568481%compared[883/2680433%areasflexneripredominantspeciesupwardtrendsonneistatisticallysignificantWHO-recommended1stlineantibioticgraduallyreached70%multiplelogisticregressionazithromycinmecillinamceftriaxonemultidrugtwofourincreasingsignificantlyp<001resultsunderscoreimportancetherapeuticinterventionsappropriatebasedcurrentantibiogramobservationsmayhelppolicymakersformulatingbettercasemanagementstrategiesshigellosis:surveillance

Similar Articles

Cited By (13)